Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Janssen Pharmaceutical Companies of Johnson & Johnson - Expanding the therapeutic opportunities in advanced prostate cancer

nmCRPC: Practical identification and current management of patients with nmCRPC

Date

29 Sep 2019

Session

Janssen Pharmaceutical Companies of Johnson & Johnson - Expanding the therapeutic opportunities in advanced prostate cancer

Presenters

Laura-Maria Krabbe

Authors

L. Krabbe

Author affiliations

  • Urology, University Hospital of Münster, 48149 - Münster/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Optimising therapeutic strategies in mHSPC

Presenter: Alvaro Pinto Marin

Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Expanding the therapeutic opportunities in advanced prostate cancer

Resources:

Webcast

Understanding advances and defining next steps

Presenter: Eleni Efstathiou

Session: Janssen Pharmaceutical Companies of Johnson & Johnson - Expanding the therapeutic opportunities in advanced prostate cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.